Source: BioPortfolio

Graftys: Graftys SA Product Pipeline Analysis 2018 Update Report Updated 09052018 Prices from USD $750

SummaryGraftys SA Graftys is a medical device company that develops manufacture and commercializes synthetic bioactive orthopedic biomaterials. The company provides range of synthetic and bioresorbable bone graft substitutes and other cement products. It o...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

Co-Founder & CEO

Jean Marc Ferrier

CEO Approval Rating

69/100

Read more